The Emerging Role of miRNAs in Myocardial Infarction: From Molecular Signatures to Therapeutic Targets
Osama A. Mohammed,Mushabab Alghamdi,Jaber Alfaifi,Mohannad Mohammad S. Alamri,Abdullah M Al-Shahrani,Muffarah Hamid Alharthi,Abdullah M. Alshahrani,Abdullah Hassan Alhalafi,Masoud I.E. Adam,Emad Bahashwan,AbdulElah Al Jarallah AlQahtani,Waad Fuad BinAfif,Mustafa Ahmed Abdel-Reheim,Sherif S. Abdel Mageed,Ahmed S. Doghish
DOI: https://doi.org/10.1016/j.prp.2023.155087
IF: 3.309
2024-01-05
Pathology - Research and Practice
Abstract:Globally, myocardial infarction (MI) and other cardiovascular illnesses have long been considered the top killers. Heart failure and mortality are the results of myocardial apoptosis, cardiomyocyte fibrosis, and cardiomyocyte hypertrophy, all of which are caused by MI. MicroRNAs (miRNAs) play a crucial regulatory function in the progression and advancement of heart disease following an MI. By consolidating the existing data on miRNAs, our aim is to gain a more comprehensive understanding of their role in the pathological progression of myocardial injury after MI and to identify potential crucial target pathways. Also included are the primary treatment modalities and their most recent developments. miRNAs have the ability to regulate both normal and pathological activity, including the key signaling pathways. As a result, they may exert medicinal benefits. This review presents a comprehensive analysis of the role of miRNAs in MI with a specific emphasis on their impact on the regeneration of cardiomyocytes and other forms of cell death, such as apoptosis, necrosis, and autophagy. Furthermore, the targets of pro- and anti-MI miRNAs are comparatively elucidated.
pathology